Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome
Clinical trial NCT02311673 · COMPLETED
Trial details
- NCT number
- NCT02311673
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-19
- Primary completion
- 2016-10-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.